MetLife Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,468	Closed	-$86.2K	–	2876
2023 Q3	$86.2K	Hold	5,468	–	–	﹤0.01%	2654
2023 Q2	$106K	Hold	5,468	–	–	﹤0.01%	2642
2023 Q1	$155K	Hold	5,468	–	–	﹤0.01%	2367
2022 Q4	$160K	Hold	5,468	–	–	﹤0.01%	2383
2022 Q3	$144K	Hold	5,468	–	–	﹤0.01%	2483
2022 Q2	$243K	Sell	5,468 -2,297	-30%	-$102K	﹤0.01%	2179
2022 Q1	$384K	Buy	7,765 +2,777	+56%	+$137K	﹤0.01%	1944
2021 Q4	$254K	Hold	4,988	–	–	﹤0.01%	1912
2021 Q3	$278K	Hold	4,988	–	–	﹤0.01%	1869
2021 Q2	$213K	Hold	4,988	–	–	﹤0.01%	2130
2021 Q1	$208K	Hold	4,988	–	–	﹤0.01%	2033
2020 Q4	$232K	Hold	4,988	–	–	﹤0.01%	1900
2020 Q3	$212K	Hold	4,988	–	–	﹤0.01%	1835
2020 Q2	$239K	Hold	4,988	–	–	﹤0.01%	1794
2020 Q1	$229K	Hold	4,988	–	–	﹤0.01%	1621
2019 Q4	$300K	Hold	4,988	–	–	﹤0.01%	1750
2019 Q3	$282K	Hold	4,988	–	–	﹤0.01%	1742
2019 Q2	$278K	Hold	4,988	–	–	﹤0.01%	1835
2019 Q1	$252K	Hold	4,988	–	–	﹤0.01%	1849
2018 Q4	$201K	Hold	4,988	–	–	﹤0.01%	1903
2018 Q3	$346K	Hold	4,988	–	–	﹤0.01%	1766
2018 Q2	$377K	Buy	4,988 +915	+22%	+$69.2K	﹤0.01%	1586
2018 Q1	$215K	Hold	4,073	–	–	﹤0.01%	1849
2017 Q4	$218K	Buy	+4,073	New	+$218K	﹤0.01%	1880